EP3417079 - NASAL BIOMARKERS OF ASTHMA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.07.2020 Database last updated on 03.09.2024 | |
Former | Request for examination was made Status updated on 23.11.2018 | ||
Former | The international publication has been made Status updated on 01.09.2017 | Most recent event Tooltip | 17.07.2020 | Application deemed to be withdrawn | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place Box 1675 New York, NY 10029 / US | [2018/52] | Inventor(s) | 01 /
BUNYAVANICH, Supinda 30 West Street-17a New York, NY 10004 / US | 02 /
PANDEY, Gaurav 2021 First Avenue-apartment 4c New York, NY 10029 / US | 03 /
SCHADT, Eric, S. 5 Graham Court Rye, NY 10580 / US | [2018/52] | Representative(s) | Goodfellow, Hugh Robin Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2018/52] | Application number, filing date | 17753896.4 | 17.02.2017 | [2018/52] | WO2017US18318 | Priority number, date | US201662296291P | 17.02.2016 Original published format: US 201662296291 P | US201662296915P | 18.02.2016 Original published format: US 201662296915 P | [2018/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017143152 | Date: | 24.08.2017 | Language: | EN | [2017/34] | Type: | A1 Application with search report | No.: | EP3417079 | Date: | 26.12.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.08.2017 takes the place of the publication of the European patent application. | [2018/52] | Search report(s) | International search report - published on: | US | 24.08.2017 | (Supplementary) European search report - dispatched on: | EP | 06.06.2019 | Classification | IPC: | C12Q1/68, G01N33/48, C40B40/08, C12Q1/6883 | [2019/28] | CPC: |
C12Q1/6883 (EP,US);
C40B40/08 (EP);
G06F17/18 (US);
G16B40/00 (US);
G16B50/10 (US);
G16B50/30 (US);
|
Former IPC [2018/52] | C12Q1/68, G01N33/48, C40B40/08 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/52] | Title | German: | NASALE BIOMARKER FÜR ASTHMA | [2018/52] | English: | NASAL BIOMARKERS OF ASTHMA | [2018/52] | French: | BIOMARQUEURS NASAUX DE L'ASTHME | [2018/52] | Entry into regional phase | 14.09.2018 | National basic fee paid | 14.09.2018 | Search fee paid | 14.09.2018 | Designation fee(s) paid | 14.09.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 14.09.2018 | Amendment by applicant (claims and/or description) | 14.09.2018 | Examination requested [2018/52] | 08.01.2020 | Application deemed to be withdrawn, date of legal effect [2020/34] | 30.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/34] | Fees paid | Renewal fee | 14.09.2018 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 29.02.2020 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]US2012289420 (MOHAPATRA SHYAM S [US], et al) [X] 1,2,13,14 * para. 10,19,20,24,38,52-58, 79 and 80 * [Y] 3-11 [I] 12; | [XYI]US2007141585 (KHURANA HERSHEY GURJIT K [US], et al) [X] 1,2,13,14 * paragraph [0016]; claims 8-12 * [Y] 3-11 [I] 12; | [A]WO2009124090 (GENENTECH INC [US], et al) [A] 1-14 * para. 2, 11, 12 and 14 *; | [A]US2009155784 (O'TOOLE MARGOT MARY [US], et al) [A] 1-14 * para. 2, 7,9, 19, 70 and 19 *; | [Y] - VIV BEWICK ET AL, "Statistics review 14: Logistic regression.", CRITICAL CARE, GB, (20050201), vol. 9, no. 1, doi:10.1186/cc3045, ISSN 1364-8535, pages 112 - 118, XP055591481 [Y] 3-11 * the whole document * DOI: http://dx.doi.org/10.1186/cc3045 | International search | [X]WO2009124090 (GENENTECH INC [US], et al) [X] 18, 19 * ; paragraph [0020] *; | [A]WO2014031859 (UNIV UTAH RES FOUND [US]) [A] 1-7, 8/1-7 * ; paragraphs [0031], [0045], [0052], [0068], [00163], [00165], [00170], [00245] *; | [A]US2009155784 (O'TOOLE MARGOT MARY [US], et al) [A] 1-7, 8/1-7 * ; abstract; paragraphs [0008], [0023], [0078]-[0079] *; | [A]US2014044702 (ARRON JOSEPH R [US], et al) [A] 1-7, 8/1-7 * ; paragraphs [0003], [0007], [0017], [0023], [0257], [0369] *; | [A]WO2011143361 (VERACYTE INC [US], et al) [A] 1-7, 8/1-7 * ; paragraphs [0008], [0040], [00124], [00167], [00169] * |